CD200/CD200R signaling maintains a resting or nonactivated microglial state (49, 50), and defects in CD200 signaling, which result in increased microglial activation, are associated with neuroinflammatory conditions such as MS and AD. The gene discussed is CD200R1; the disease is myeloid sarcoma.